Covance sells UK preclinical lab to Shott Trinova LLP
Covance has sold its preclinical research unit in Alnwick, UK to ARC Trinova, a new entity formed by investment group Shott Trinova LLP.
Archives for February 22, 2016
AAI/Cambridge Major Labs to rehouse anaytical services in new MO facility
Increased client demand for analytical testing has driven merged CDMO AAIPharma/Cambridge Major Laboratories to invest $11m into a new facility in Missouri.
ScinoPharm: expanding scope, more products in pipeline, says CEO
ScinoPharm Taiwan announced its unaudited financial results for fiscal year 2015, and with it, plans to expand its contract businesses through strategic acquisitions.
Momenta: Sandoz capable of countering Teva’s Copaxone protection strategy
Teva has aggressively defended its market share for its blockbuster Copaxone says Momenta, six months after marketing partner Sandoz launched the first generic version in the US.
Ciproflaxin resistance spreading says taskforce calling on drug industry for new antibiotics
Bacterial resistance to ciproflaxin is spreading according to the European CDC which wants the drug industry to invest in development of alternatives to the "last resort" antibiotic.
MHRA concerned about pharma's preparedness for excipient risk assessments
There are concerns that pharma companies are not fully prepared to meet the new requirements on risk-assessment for excipients, even though the deadline is just a few weeks away.
Nuevolution discovery platform earns $2m from Novartis; new twist in patent case against ex CSO
Nuevolution has been paid a $2m (€1.8m) milestone by drug discovery platform licensee Novartis.
These are the leads you're looking for: LIGHTSABR could slash discovery costs
Screening compound libraries is an important method for discovering new drugs, but has required a large, expensive facility – until now.
Powder study will help safeguard $12bn Danish drug industry, say scientists
Research examining how API particle characteristics impact drug stability will help safeguard Denmark’s $12bn (DKK80bn) a year drug manufacturing industry say scientists.